140 related articles for article (PubMed ID: 7692102)
21. Intravesical prostatic protrusion can predict therapeutic response to silodosin in male patients with lower urinary tract symptoms.
Matsukawa Y; Ishida S; Majima T; Funahashi Y; Sassa N; Kato M; Yoshino Y; Gotoh M
Int J Urol; 2017 Jun; 24(6):454-459. PubMed ID: 28370376
[TBL] [Abstract][Full Text] [Related]
22. Thermo-expandable prostatic stents for bladder outlet obstruction in the frail and elderly population: An underutilized procedure?
Sethi K; Bozin M; Jabane T; McMullin R; Cook D; Forsyth R; Dodds L; Putra LJ
Investig Clin Urol; 2017 Nov; 58(6):447-452. PubMed ID: 29124245
[TBL] [Abstract][Full Text] [Related]
23. Efficacy of silodosin for relieving benign prostatic obstruction: prospective pressure flow study.
Matsukawa Y; Gotoh M; Komatsu T; Funahashi Y; Sassa N; Hattori R
J Urol; 2009 Dec; 182(6):2831-5. PubMed ID: 19837428
[TBL] [Abstract][Full Text] [Related]
24. Combination of intravesical prostatic protrusion and resistive index is useful to predict bladder outlet obstruction in patients with lower urinary tract symptoms suggestive of benign prostatic hyperplasia.
Suzuki T; Otsuka A; Ozono S
Int J Urol; 2016 Nov; 23(11):929-933. PubMed ID: 27545297
[TBL] [Abstract][Full Text] [Related]
25. Is there a role for transrectal microwave hyperthermia in the treatment of benign prostatic hyperplasia? A critical review of a six-year experience.
Montorsi F; Guazzoni G; Rigatti P; Pizzini G; Miani A
J Endourol; 1995 Aug; 9(4):333-7. PubMed ID: 8535463
[TBL] [Abstract][Full Text] [Related]
26. The 12-year outcome analysis of an endourethral wallstent for treating benign prostatic hyperplasia.
Masood S; Djaladat H; Kouriefs C; Keen M; Palmer JH
BJU Int; 2004 Dec; 94(9):1271-4. PubMed ID: 15610103
[TBL] [Abstract][Full Text] [Related]
27. Efficacy of silodosin for relieving benign prostatic obstruction: prospective pressure flow study.
Matsukawa Y; Gotoh M; Komatsu T; Funahashi Y; Sassa N; Hattori R
J Urol; 2013 Jan; 189(1 Suppl):S117-21. PubMed ID: 23234615
[TBL] [Abstract][Full Text] [Related]
28. Holmium laser enucleation versus photoselective vaporization for prostatic adenoma greater than 60 ml: preliminary results of a prospective, randomized clinical trial.
Elmansy H; Baazeem A; Kotb A; Badawy H; Riad E; Emran A; Elhilali M
J Urol; 2012 Jul; 188(1):216-21. PubMed ID: 22591968
[TBL] [Abstract][Full Text] [Related]
29. [Clinical significance of residual urine volume in bladder outlet obstruction with benign prostatic hyperplasia].
Wu Z; Wu K; Wang B
Zhonghua Wai Ke Za Zhi; 1997 Jun; 35(6):374-6. PubMed ID: 10374477
[TBL] [Abstract][Full Text] [Related]
30. A self-expanding prostatic stent for bladder outlet obstruction in high risk patients.
Morgentaler A; DeWolf WC
J Urol; 1993 Nov; 150(5 Pt 2):1636-40. PubMed ID: 7692101
[TBL] [Abstract][Full Text] [Related]
31. A temporary intraurethral prostatic stent relieves prostatic obstruction following transurethral microwave thermotherapy.
Shore ND; Dineen MK; Saslawsky MJ; Lumerman JH; Corica AP
J Urol; 2007 Mar; 177(3):1040-6. PubMed ID: 17296408
[TBL] [Abstract][Full Text] [Related]
32. Holmium:YAG transurethral incision versus laser photoselective vaporization for benign prostatic hyperplasia in a small prostate.
Elshal AM; Elkoushy MA; Elmansy HM; Sampalis J; Elhilali MM
J Urol; 2014 Jan; 191(1):148-54. PubMed ID: 23845460
[TBL] [Abstract][Full Text] [Related]
33. Clinical evaluation of patients with prostatic obstruction: correlation of flow rates with voided, residual or total bladder volume.
Drach GW; Steinbronn DV
J Urol; 1986 Apr; 135(4):737-40. PubMed ID: 2421016
[TBL] [Abstract][Full Text] [Related]
34. Feasibility of holmium laser enucleation of the prostate (HoLEP) for recurrent/residual benign prostatic hyperplasia (BPH).
Elshal AM; Elmansy HM; Elhilali MM
BJU Int; 2012 Dec; 110(11 Pt C):E845-50. PubMed ID: 22702908
[TBL] [Abstract][Full Text] [Related]
35. Decreased urinary nerve growth factor reflects prostatic volume reduction and relief of outlet obstruction in patients with benign prostatic enlargement treated with dutasteride.
Wada N; Matsumoto S; Kita M; Hashizume K; Kakizaki H
Int J Urol; 2014 Dec; 21(12):1258-62. PubMed ID: 25039474
[TBL] [Abstract][Full Text] [Related]
36. The use of prostatic stents in patients with urinary retention who are unfit for surgery. An interim report.
McLoughlin J; Jager R; Abel PD; el Din A; Adam A; Williams G
Br J Urol; 1990 Jul; 66(1):66-70. PubMed ID: 1697492
[TBL] [Abstract][Full Text] [Related]
37. Clinical diagnosis of bladder outlet obstruction in patients with benign prostatic enlargement and lower urinary tract symptoms: development and urodynamic validation of a clinical prostate score for the objective diagnosis of bladder outlet obstruction.
Rosier PF; de Wildt MJ; Wijkstra H; Debruyne FF; de la Rosette JJ
J Urol; 1996 May; 155(5):1649-54. PubMed ID: 8627845
[TBL] [Abstract][Full Text] [Related]
38. [The relationship between intravesical prostatic protrusion and pressure flow study findings in patients with benign prostate obstruction/lower urinary tract symptoms].
Park SC; Lee JW; Rim JS
Actas Urol Esp; 2012 Mar; 36(3):165-70. PubMed ID: 22018947
[TBL] [Abstract][Full Text] [Related]
39. Urinary flow rate in benign prostatic hypertrophy.
Anikwe RM
Int Surg; 1976 Feb; 61(2):109-11. PubMed ID: 56317
[TBL] [Abstract][Full Text] [Related]
40. [Residual fraction in the evaluation of bladder outlet obstruction resulting from benign prostatic hyperplasia].
Cheng W; Gao JP; Zhang ZY; Ge JP; Xue S
Zhonghua Nan Ke Xue; 2003; 9(4):273-4. PubMed ID: 12931369
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
